EPRONTIA™已被批准作为单一疗法,用于治疗2岁及以上患者的部分发作或原发性全身强直-阵挛发作;作为辅助疗法,用...查看全文
美港电讯APP2021-08-06 16:28
$Eton Pharmaceuticals(ETON)$ 盘前涨10.4%,美国食品药品监督管理局(FDA)今日将审核是否批准Eton Pharmaceuticals治疗癫痫的口服新药。(来自美港电讯APP)查看全文
$Eton Pharmaceuticals(ETON)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-21-024351 Act: 34 Size: 32 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 5 Annual statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-003826 Size: 4 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-21-002865 Act: 34 Size: 48 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-21-001005 Act: 34 Size: 41 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-20-023811 Act: 34 Size: 40 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001832154-20-000004 Act: 34 Size: 62 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-20-021131 Act: 34 Size: 3 MB 网页链接
$Eton Pharmaceuticals(ETON)$ 内部交易: 2020-10-16,10% Owner,Opaleye Management Inc. ,买入,400000普通股, $7.00
$Eton Pharmaceuticals(ETON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-20-019587 Size: 7 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-20-019583 Act: 34 Size: 39 KB 网页链接